T. Rowe Price Associates’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,356	Closed	-$144K	–	3005
2021 Q2	$144K	Sell	19,356 -3,571	-16%	-$26.6K	﹤0.01%	2781
2021 Q1	$186K	Buy	22,927 +11,710	+104%	+$95K	﹤0.01%	2703
2020 Q4	$102K	Buy	+11,217	New	+$102K	﹤0.01%	2622